6533b7ddfe1ef96bd1274588
RESEARCH PRODUCT
REMINET : A European, Multicenter, Phase II/III Randomized Double-Blind, Placebo-Controlled Study Evaluating Lanreotide As Maintenance Therapy after First-Line Treatment in Patients with Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors
C. LepageL. DahanJ.-l. LegouxK. Le MalicotR. GuimbaudD. TougeronA. LievreN. BouariouaC. PetorinM. PavelI. BorbathC. ToumpanakisD. SmithM. DucreuxT. Waltersubject
Clinical trial[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismDuodeno-pancreatic neuroendocrine tumoursMaintenance[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismComputingMilieux_MISCELLANEOUSdescription
International audience
year | journal | country | edition | language |
---|---|---|---|---|
2017-03-08 |